• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,328.19 -516.33
( -0.66%)
Global Indices
Nasdaq
49,619.91 1.93
(0.00%)
Dow Jones
7,417.79 59.68
(0.81%)
Hang Seng
62,681.30 -152.54
(-0.24%)
Nikkei 225
10,228.01 -48.94
(-0.48%)
Forex
USD-INR
94.38 -0.30
(-0.31%)
EUR-INR
110.93 -0.26
(-0.23%)
GBP-INR
128.32 -0.39
(-0.30%)
JPY-INR
0.60 0.00
(-0.28%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
99.2482659
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
101.56
443229.15
EPS(TTM)
Face Value()
Div & Yield %
18.19
1
0.87
 

C & C Constructions reports consolidated net loss of Rs 27.05 crore in the March 2026 quarter
May 07,2026
Net loss of C & C Constructions reported to Rs 27.05 crore in the quarter ended March 2026 as against net profit of Rs 3.84 crore during the previous quarter ended March 2025. Sales reported to Rs 20.10 crore in the quarter ended March 2026. There were no Sales reported during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 28.80 crore in the year ended March 2026 as against net loss of Rs 23.78 crore during the previous year ended March 2025. Sales reported to Rs 20.10 crore in the year ended March 2026. There were no Sales reported during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales20.100 0 20.100 0
OPM %-139.650 --158.910 -
PBDT-26.904.00 PL -28.21-23.19 -22
PBT-27.053.84 PL -28.80-23.78 -21
NP-27.053.84 PL -28.80-23.78 -21